BACKGROUND Few studies have assessed elderly patients with Takayasu's arteritis (TAK). OBJECTIVES To evaluate the progression of TAK in different age groups and its possible effects on drug treatment and… Click to show full abstract
BACKGROUND Few studies have assessed elderly patients with Takayasu's arteritis (TAK). OBJECTIVES To evaluate the progression of TAK in different age groups and its possible effects on drug treatment and disease activity. METHODS This cross-sectional and retrospective cohort study included 66 TAK patients. Patients were interviewed and data of the 12 preceding months were collected from electronic medical records. The patients were divided into four quartiles according to current age and compared for clinical and laboratory data, treatment, comorbidities, disease status, and functional status. Statistical significance was set at p<0.05. RESULTS The groups were Q1(22-36 years, n=16), Q2(37-42 years, n=18), Q3(43-49 years, n=17), and Q4(51-66 years, n=15). The frequency of patients with disease activity, fatigue, comorbidities and vascular impairments, and the TAK disease extent index were also comparable between the groups. With age, disease duration was longer (p=0.001), fewer patients used prednisone (Q1:43.8%, Q2:33.3%, Q3:11.8%, and Q4:6.7%; p=0.049) and immunosuppressive drugs [Q1:100.0%, Q2:66.7%, Q3:58.8%, and Q4:46.7%; Q1 versus Q3 (p=0.043), and Q1 versus Q4 (p=0.005) in post-hoc analyses], and patients had greater functional status impairment (Q2 versus Q3, p=0.003). In addition, the levels of disease damage, new TAK symptoms, and complications in the preceding 12 months were not different between the groups. CONCLUSIONS Older patients with TAK require minimal drug treatment, and have greater impairment of functional status, which may be attributed to aging-related factors.
               
Click one of the above tabs to view related content.